Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
Public ClinicalTrials.gov record NCT01210352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Non-randomized, Multicenter, Ascending Dose by Age, Single- and Multiple-Dose Evaluation of the Effectiveness, Safety, and Tolerability of Oral Liquid Oxymorphone HCl Immediate-Release Oral Liquid for Acute Postoperative Pain in Pediatric Subjects
Study identification
- NCT ID
- NCT01210352
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- oxymorphone HCl Drug
Drug
Eligibility (public fields only)
- Age range
- 0 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2010
- Primary completion
- Oct 5, 2017
- Completion
- Oct 5, 2017
- Last update posted
- Aug 19, 2021
2010 – 2017
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Clinical Trial Site #19 | Tucson | Arizona | 85724 | — |
| Endo Clinical Trial Site #1 | Little Rock | Arkansas | 72202 | — |
| Endo Clinical Trial Site #3 | Aurora | Colorado | 80045 | — |
| Endo Clinical Trial Site #6 | Indianapolis | Indiana | 46202 | — |
| Endo Clinical Trial Site #11 | Oklahoma City | Oklahoma | 73104 | — |
| Endo Clinical Trial Site #12 | Pittsburgh | Pennsylvania | 15224 | — |
| Endo Clinical Trial Site #13 | Nashville | Tennessee | 37232 | — |
| Endo Clinical Trial Site #14 | Dallas | Texas | 75235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01210352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01210352 live on ClinicalTrials.gov.